Your browser doesn't support javascript.
loading
Pharmacologic profiling of patient-derived xenograft models of primary treatment-naïve triple-negative breast cancer.
Powell, Reid T; Redwood, Abena; Liu, Xuan; Guo, Lei; Cai, Shirong; Zhou, Xinhui; Tu, Yizheng; Zhang, Xiaomei; Qi, Yuan; Jiang, Yan; Echeverria, Gloria; Feng, Ningping; Ma, XiaoYan; Giuliani, Virginia; Marszalek, Joseph R; Heffernan, Timothy P; Vellano, Christopher P; White, Jason B; Stephan, Clifford; Davies, Peter J; Moulder, Stacy; Symmans, W Fraser; Chang, Jeffrey T; Piwnica-Worms, Helen.
Afiliação
  • Powell RT; Center for Translational Cancer Research, Texas A&M University, Houston, TX, USA.
  • Redwood A; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Liu X; Department of Integrative Biology and Pharmacology, UT Health Science Center, Houston, TX, USA.
  • Guo L; Center for Translational Cancer Research, Texas A&M University, Houston, TX, USA.
  • Cai S; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Zhou X; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Tu Y; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Zhang X; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Qi Y; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Jiang Y; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Echeverria G; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Feng N; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ma X; TRACTION Platform, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Giuliani V; TRACTION Platform, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Marszalek JR; TRACTION Platform, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Heffernan TP; TRACTION Platform, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Vellano CP; TRACTION Platform, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • White JB; TRACTION Platform, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Stephan C; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Davies PJ; Center for Translational Cancer Research, Texas A&M University, Houston, TX, USA.
  • Moulder S; Center for Translational Cancer Research, Texas A&M University, Houston, TX, USA.
  • Symmans WF; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Chang JT; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Piwnica-Worms H; Department of Integrative Biology and Pharmacology, UT Health Science Center, Houston, TX, USA.
Sci Rep ; 10(1): 17899, 2020 10 21.
Article em En | MEDLINE | ID: mdl-33087803

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ensaios Antitumorais Modelo de Xenoenxerto / Neoplasias de Mama Triplo Negativas / Antineoplásicos Limite: Animals / Female / Humans Idioma: En Revista: Sci Rep Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ensaios Antitumorais Modelo de Xenoenxerto / Neoplasias de Mama Triplo Negativas / Antineoplásicos Limite: Animals / Female / Humans Idioma: En Revista: Sci Rep Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos